| Code | Description | Claims | Beneficiaries | Total Paid |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
60,127 |
54,137 |
$4.55M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
11,334 |
10,762 |
$524K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,205 |
3,059 |
$445K |
| 88342 |
|
2,889 |
2,826 |
$63K |
| 88341 |
|
523 |
506 |
$48K |
| 88312 |
|
1,269 |
1,262 |
$43K |
| 88304 |
|
1,285 |
1,264 |
$39K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,569 |
1,440 |
$9K |
| 88313 |
|
141 |
137 |
$5K |